What is FoxEyes?
Founded in 2024 and headquartered in DFW, Texas, FoxEyes Corporation is dedicated to the development of high-precision robotic surgical equipment. The company distinguishes itself by integrating sophisticated artificial intelligence into its hardware, aiming to enhance both the safety and user-friendliness of automated surgical interventions. By focusing on the intersection of robotics and medical efficacy, FoxEyes provides versatile solutions designed to meet the rigorous demands of modern healthcare professionals. Their market position is defined by a commitment to technological evolution, ensuring that surgical robotics become a practical, reliable reality in clinical environments worldwide.
How much funding has FoxEyes raised?
FoxEyes has raised a total of $540K across 2 funding rounds:
Stock/Share Issuance
$330K
Stock/Share Issuance
$210K
Stock/Share Issuance (2025): $330K, investors not publicly disclosed
Stock/Share Issuance (2025): $210K, investors not publicly disclosed
Key Investors in FoxEyes
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for FoxEyes?
With this major strategic investment, FoxEyes is poised to enter a critical growth phase characterized by aggressive product iteration and market expansion. The company will likely prioritize the refinement of its AI-driven surgical platforms and the establishment of deeper partnerships within the global medical community. As the firm scales its operations, the focus will shift toward regulatory milestones and the deployment of its robotic systems into high-acuity surgical settings. This capital infusion provides the necessary runway to solidify its competitive advantage in the medical technology landscape, setting the stage for long-term sustainability and innovation in the surgical robotics domain.
See full FoxEyes company page
